Average Co-Inventor Count = 9.88
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Compugen Ltd. Corporation (17 from 60 patents)
2. Protalix Ltd. (1 from 25 patents)
17 patents:
1. 9428586 - Heparanase splice variant
2. 9409987 - Polypeptides and polynucleotides, and uses thereof for treatment of immune related disorders and cancer
3. 8987191 - Bioactive peptides and methods of using same
4. 8828940 - Method of treating an ischemia-reperfusion injury-related disorder by administering GPCR ligands
5. 8492329 - Bioactive peptides and methods of using same
6. 8349801 - Peptide ligands for G-protein coupled receptors
7. 7939634 - Polynucleotides encoding polypeptides and methods using same
8. 7906635 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer
9. 7884180 - Peptides which bind to G protein-coupled receptors
10. 7842459 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
11. 7714100 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease
12. 7667001 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer
13. 7655781 - Variants of human glycoprotein hormone alpha chain: compositions and uses thereof
14. 7569662 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer
15. 7553948 - Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer